On the heels of the news that Amazon subsidiary PillPack is paying $5.79 million to the U.S. and various states for fraudulently over-billing for insulin and over-dispensing the drug, three sources, including former and current Amazon Pharmacy employees, tell Axios the practice was widely acknowledged and that higher-ups dismissed staff concerns about the matter.
Why it matters: Amazon is a stalwart in the health tech sector, with sprawling efforts across virtual and in-person care, medical supplies, diagnostics and pharmacy.
